Analysis of Late Toxicity in Nasopharyngeal Carcinoma Patients Treated with Intensity Modulated Radiation Therapy

Overview

Journal Radiat Oncol

Publisher Biomed Central

Specialties Oncology
Radiology

Date 2015 Jan 14

PMID 25582731

Citations 44

Authors

Yingjie Zheng

Fei Han

Weiwei Xiao

Yanqun Xiang

Lixia Lu

Xiaowu Deng

NianJi Cui

Chong Zhao

Affiliations

Soon will be listed here.

Abstract

Purpose: To observe the late toxicities in nasopharyngeal carcinoma (NPC) patients who achieved long-term survival after intensity modulated radiation therapy (IMRT).

Methods: 208 untreated NPC patients who received IMRT and survived more than five years with locoregional disease control and no metastasis were evaluated in this study. The prescription dose to the gross target volume of nasopharynx (GTVnx), positive neck lymph nodes (GTVnd), clinical target volume 1 (CTV1) and 2 (CTV2) was 68Gy/30f, 60-66Gy/30f, 60 Gy/30f and 54Gy/30f, respectively. The nasopharynx and upper neck targets were irradiated using IMRT, and the lower neck and supraclavicular fossae targets were irradiated using the half-beam technique with conventional irradiation. The late toxicities were evaluated according to the LENT/SOMA criteria of 1995.

Results: The median follow-up time was 78 months (60-96 months). The occurrence rates of cervical subcutaneous fibrosis, hearing loss, skin dystrophy, xerostomia, trismus, temporal lobe injury, cranial nerve damage, cataract, and brain stem injury induced by radiotherapy were 89.9%, 67.8%, 47.6%, 40.9%, 7.21%, 4.33%, 2.88%, 1.44%, and 0.48%, respectively. No spinal cord injury and mandible damage were found. Grade 3-4 late injuries were observed as follows: 1 (0.48%) skin dystrophy, 4 (1.92%) cervical subcutaneous fibrosis, 2 (0.96%) hearing loss, 2 (0.96%) cranial nerve palsy, and 1 (0.48%) temporal lobe necrosis. No grade 3-4 late injuries occurred in parotid, temporomandibular joints and eyes. Xerostomia decreased gradually over time and then showed only slight changes after 4 years. The change in the incisor distance stabilised by 1 year after RT, however, the incidence of hearing loss, skin dystrophy, subcutaneous fibrosis and nervous system injuries increased over time after RT.

Conclusion: The late injuries in most NPC patients who had long-term survivals after IMRT are alleviated. Within the 5 years of follow-up, we found xerostomia decreased gradually; The change in the incisor distance stabilised by 1 year after RT; while hearing loss, nervous system injuries increased over time after RT.

Citing Articles

Optimizing the cumulative cisplatin dose for concurrent chemoradiotherapy beneficiaries among elderly nasopharyngeal carcinoma patients: a real world study.

Wu Y, He S, He D, Gao Y, Huang Y, Jing J Sci Rep. 2024; 14(1):30652.

PMID: 39730329 PMC: 11680703. DOI: 10.1038/s41598-024-69811-8.

Multifactorial clinical analysis of factors affecting necrosis of nasal septal mucosal flap after salvage surgery for recurrent nasopharyngeal carcinoma.

Gong Q, Li H, Liu H, Shi Y Sci Rep. 2024; 14(1):29287.

PMID: 39592834 PMC: 11599838. DOI: 10.1038/s41598-024-80800-9.

Dosimetric Comparison and Selection Criteria of Intensity-Modulated Proton Therapy and Intensity-Modulated Radiation Therapy for Adaptive Re-Plan in T3-4 Nasopharynx Cancer Patients.

Ko M, Yang K, Ahn Y, Ju S, Oh D, Kim Y Cancers (Basel). 2024; 16(19).

PMID: 39410022 PMC: 11476283. DOI: 10.3390/cancers16193402.

Optimizing Hearing Outcomes in Nasopharyngeal Cancer Survivors in the Era of Modern Radiotherapy and Systemic Therapy.

Ho J, Ma B, Chow J Cancers (Basel). 2024; 16(18).

PMID: 39335208 PMC: 11430699. DOI: 10.3390/cancers16183237.

The role of prehabilitation in HNSCC patients treated with chemoradiotherapy.

Gili R, Gianluca S, Paolo A, Federica S, Paola L, Simone C Support Care Cancer. 2024; 32(10):638.

PMID: 39235658 PMC: 11377665. DOI: 10.1007/s00520-024-08834-3.

References

Lee A, Sze W, Yau T, Yeung R, Chappell R, Fowler J . Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity. Radiother Oncol. 2001; 58(2):121-30. DOI: 10.1016/s0167-8140(00)00312-1. View

Wu F, Wang R, Lu H, Wei B, Feng G, Li G . Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study. Radiother Oncol. 2014; 112(1):106-11. DOI: 10.1016/j.radonc.2014.05.005. View

Lee N, Xia P, Quivey J, Sultanem K, Poon I, Akazawa C . Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002; 53(1):12-22. DOI: 10.1016/s0360-3016(02)02724-4. View

Au J, Law C, Foo W, Lau W . In-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma: prognostic homogeneity and proposed refinements. Int J Radiat Oncol Biol Phys. 2003; 56(2):413-26. DOI: 10.1016/s0360-3016(02)04610-2. View

Eisbruch A, Ship J, Dawson L, Kim H, Bradford C, Terrell J . Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg. 2003; 27(7):832-7. DOI: 10.1007/s00268-003-7105-6. View

Kwong D, Pow E, Sham J, McMillan A, Leung L, Leung W . Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer. 2004; 101(7):1584-93. DOI: 10.1002/cncr.20552. View

Perez C, Devineni V, Marks J, Simpson J, Kucik N . Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys. 1992; 23(2):271-80. DOI: 10.1016/0360-3016(92)90741-y. View

Pavy J, Denekamp J, Letschert J, LITTBRAND B, Mornex F, Bernier J . EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys. 1995; 31(5):1043-7. DOI: 10.1016/0360-3016(95)00059-8. View

Cooper J, Fu K, Marks J, Silverman S . Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys. 1995; 31(5):1141-64. DOI: 10.1016/0360-3016(94)00421-G. View

10.

Sanguineti G, Geara F, Garden A, Tucker S, Ang K, Morrison W . Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys. 1997; 37(5):985-96. DOI: 10.1016/s0360-3016(97)00104-1. View

11.

Yeh S, Tang Y, Lui C, Huang Y, Huang E . Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys. 2005; 62(3):672-9. DOI: 10.1016/j.ijrobp.2004.11.002. View

12.

Hsiung C, Ting H, Huang H, Lee C, Huang E, Hsu H . Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2006; 66(2):454-61. DOI: 10.1016/j.ijrobp.2006.04.033. View

13.

Pow E, Kwong D, McMillan A, Wong M, Sham J, Leung L . Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006; 66(4):981-91. DOI: 10.1016/j.ijrobp.2006.06.013. View

14.

Sumitsawan Y, Chaiyasate S, Chitapanarux I, Anansuthiwara M, Roongrotwattanasiri K, Vaseenon V . Late complications of radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx. 2008; 36(2):205-9. DOI: 10.1016/j.anl.2008.04.006. View

15.

Lee A, Ng W, Hung W, Choi C, Tung R, Ling Y . Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Int J Radiat Oncol Biol Phys. 2008; 73(4):1121-8. DOI: 10.1016/j.ijrobp.2008.05.023. View

16.

Xiao W, Huang S, Han F, Wu S, Lu L, Lin C . Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer. 2011; 117(9):1874-83. DOI: 10.1002/cncr.25754. View

17.

Chen Y, Zhao C, Wang J, Ma H, Lai S, Liu Y . Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up. Cancer. 2011; 117(13):2910-6. DOI: 10.1002/cncr.25773. View

18.

Su S, Huang S, Han F, Huang Y, Chen C, Xiao W . Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy. Radiat Oncol. 2013; 8:17. PMC: 3573909. DOI: 10.1186/1748-717X-8-17. View

19.

Zhou G, Yu X, Chen M, Guo R, Lei Y, Sun Y . Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy. PLoS One. 2013; 8(7):e67488. PMC: 3707870. DOI: 10.1371/journal.pone.0067488. View

20.

Wang W, Feng M, Fan Z, Li J, Lang J . Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Biomed Res Int. 2014; 2014:814948. PMC: 4139082. DOI: 10.1155/2014/814948. View